Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19
2020
Summary: Patients with hematologic malignancies have increased susceptibility to viral infections and suboptimal immunologic responses to current vaccines due to both disease-associated and therapy-related immune dysfunction. These considerations may impact the efficacy of emerging COVID-19 vaccines in this patient population as well and warrant the need to systematically study natural and vaccine-induced virus-specific immunity in these patients.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
4
Citations
NaN
KQI